Try our Advanced Search for more refined results
8,097,405
Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs
- August 07, 2019 Fed. Circ. Urged To Reconsider Enzo DNA Patent Case
- July 24, 2019 Fed. Circ. Highlights Need For Enabling Disclosure In Patents
- June 25, 2019 Enzo's DNA Testing Patents Don't Hold Up, Fed. Circ. Affirms
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login